Endo Tool Therapeutics raised $5.7 million (€5 million) in a series C financing round, which the company will use to support future studies and device development, Mass Device reports.
What you should know:
1. Epimède led the round, joined by several current investors.
2. Epimède Co-founder Philippe Degeer will join the company's board of directors.
3. Endo Tool will also use the funds to support the continued development of its Endomina, endoscopy platform.
4. Endo Tool CEO Alexandre Chau said in a statement, "With technical and regulatory challenges behind us, these funds will allow Endo Tools Therapeutics to achieve further proof of efficacy of treatments performed with our devices, as well as wider adoption."